Stay updated on Uproleselan High Dose Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.

Latest updates to the Uproleselan High Dose Combo in AML Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.4%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision entry v3.7.0 appears in the study record history, indicating an update to the record's revision history. The previous revision v3.6.6 is removed from the history.SummaryDifference0.1%

- Check56 days agoChange DetectedA new page revision entry v3.6.6 was added and the previous v3.6.5 was removed. This reflects an underlying system update to the page rather than a change to study data.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, indicating a routine system update rather than a change to visible content.SummaryDifference0.1%

Stay in the know with updates to Uproleselan High Dose Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.